Purdue Seeks To Stop Watson's Reformulated Oxy Generic
Purdue Pharma LP is once again taking Watson Pharmaceuticals Inc. to court over its plans to market generic OxyContin, filing suit Tuesday in New York federal court to block Watson's attempts...To view the full article, register now.
Already a subscriber? Click here to view full article